Tag Archives: vitamin D

The impact of vitamin D(3) on bone remodeling in different types of experimental pathology

A. O. Mazanova*, O. O. Makarova, A. V. Khomenko, V. M. Vasylevska,
O. Yu. Lototska, I. O. Shymanskyi, M. M. Veliky

Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;
*e-mail: ann.mazanova@gmail.com

Received: 17 June 2022; Revised: 28 July 2022;
Accepted: 29 September 2022; Available on-line: 06 October 2022

Osteoporosis is a progressive systemic skeletal disease characterized by a decrease in bone density, impairment of its microarchitectonics, and an increased risk of fractures that occur under minimal or no mechanical stress. One of the main causes of osteoporosis is vitamin D deficiency, which leads to disruption of normal bone remodeling. The aim of our study was to analyze the features of the process of bone tissue remodeling by measuring the key biochemical markers of bone formation/resorption in primary and secondary osteoporosis, as well as to investigate the potential corrective effect of vitamin D3 supplementation. The work was conducted on rats with different osteoporosis models: alimentary, dysfunctional and secondary osteoporosis associated with diabetes mellitus. We used ELISA to measure 25(OH)D content in blood serum. Blood serum and bone tissue calcium, and alkaline phosphatase activity were determined with bioassay kits. The content of inorganic phosphate in blood serum and ash was assayed by the Dyce method. It was shown that all the studied pathological conditions were accompanied by vitamin D deficiency, which led to impaired absorption of calcium in the intestine and reabsorption of inorganic phosphates by the kidneys, reducing, as a result, their concentration in the blood serum. Hypocalcemia and hypophosphatemia contributed to the disruption of normal bone remodeling, excessive activation of alkaline phosphatase, and a decrease in the content of calcium and phosphate in bone tissue. Thus, sufficient vitamin D bioavailability was confirmed to be critical for effective bone remodeling in primary and secondary osteoporosis.

Indicators of mineral metabolism and dental status of young rats born from female with methionine-induced hyperhomocysteinemia

O. Kutelmakh1*, R. Lesyk2,3, Yu. Chumakova4,
S. Bondar1, V. Dronenko1, L. Shkilniak1

1Vinnytsia National Pirogov Memorial Medical University, Vinnytsya, Ukraine;
2Danylo Halytsky Lviv National Medical University, Lviv, Ukraine;
3University of Information Technology and Management in Rzeszow, Rzeszow, Poland;
4International Humanitarian University, Odessa, Ukraine;
*e-mail: ahzelo1968vin@i.ua

Received: 12 July 2021; Accepted: 12 November 2021

We assume that the violation of homocysteine (Hcy) metabolism and vitamin D level in mothers’ utero causes various abnormalities in offspring, including hard-woven teeth and periodontium impairments. The aim of this study was to evaluate the biochemical parameters of blood and alveolar bone homogenates and assess dental status of offspring born from female rats under long-term methionine hyperhomocysteinemia (HHcy). Clinical, biochemical and morphometric studies were performed on 30 female rats and 281 infantile and early juvenile rats. Serum Hcy levels were determined by competitive immunoassay with electrochemiluminescent detection, 25-hydroxyvitamin D (25OHD) level was estimated  by ELISA. No violation of Hcy serum level was found in rats born from females with long-term methionine-induced hyperhomocysteinaemia. Hyperhomocysteinaemic diet caused by long-term use of methionine reduced the level of total and ionized calcium and phosphates in the blood of pregnant females and their offspring. Elevated levels of homocysteine and decreased vitamin D levels in pregnant females caused a delay in the complete physiological eruption of permanent molars in their offspring. Biochemical changes in the blood, jawbones and the presence of early carious processes in the teeth of young rats, in our opinion, are the result of metabolic disorders in utero caused by hyperhomocysteinaemia and vitamin D deficiency in their mothers.

Serum levels of alpha-melanocyte stimulating hormone, vitamin D, calcium, phosphorus and magnesium in COVID-19 patients

S. Z. Hussein1, M. A. Abdalla2*

1Clinical Biochemistry Unit, Salah Aldeen Health Directorate, Tikrit, Iraq;
2Department of Human Anatomy, Tikrit University College of Medicine, Tikrit, Iraq;
*e-mail: dr.mohammad68@tu.edu.iq

Received: 04 April 2021; Accepted: 12 November 2021

The COVID-19 pandemic occurred and quickly spread throughout the world. To improve the state of COVID-19 patients, it is important to identify the possible clinical differential diagnostic markers and their correlation with the severity of SARS-CoV-2 infection. In this study, the serum level of alpha-melanocyte stimulating hormone (alpha-MSH), vitamin D, calcium, phosphorus and magnesium in the serum of COVID-19 patients were analyzed. Blood samples were collected from 60 patients who attended Isolated Hospital in Tikrit City/Iraq from September to December 2020 and diagnosed by RT-PCR as COVID-19 positive and from 30 healthy individuals. It was shown that COVID-19 patients revealed high serum levels of α-MSH as compared with healthy individuals but low serum levels of vitamin D, calcium, and magnesium which may be recommended as supplements for those patients to increase the innate immune response.